1REALM Unified Services Platform
1REALM Unified Services Platform is an integrated global network that brings together clinical research, patient engagement and advocacy, analytical services, logistics and operations, and manufacturing to enable advanced cell and gene therapies at the point of care. By aligning these essential disciplines within a single, interoperable framework, the platform streamlines deployment, safeguards quality, shortens development timelines and broadens access to transformative treatments worldwide.
REALM Bio integrates experienced clinical professionals inside partner hospitals or will collaborates with sponsor CROs and partners to extend their global reach and deliver full-service clinical capabilities on site. With infrastructure and staff ready for qualification, each location is positioned for rapid study activation and connects to regional medical centers to expand patient reach and support consistent enrollment.
The Global Access Alliance for Advanced Therapies, a 501(c)(3) non-profit founded by REALM Bio, unites technical experts, patients, providers and the global communities we serve. Engagement and advocacy drive our mission to lower cost barriers and expand equitable access to advanced therapies. We are also committed to building a sustainable local biotech ecosystem by training and placing individuals directly into the evolving industry.
REALM Bio's analytical lab services establish a state-of-the-art facility right at the point of care, fully integrated with our clinical and manufacturing operations. We empower local staff, fostering a sustainable, high-quality biotech ecosystem within each region where we operate.
Our logistics and operations team orchestrates the full lifecycle of critical biologics – from initial strategy and planning through precision movement and on-time delivery. Acting as a single control tower for both on-site hubs and mobile units, we integrate Quality Assurance, Regulatory Affairs and operational experts to safeguard product integrity, ensure compliance and keep every therapy on schedule.
REALM Bio embeds full-scale cell, gene, and CAR-T manufacturing labs – whether on-site at medical centers, within our dedicated production centers, or as GMP-compliant mobile manufacturing units. Each site becomes a self-sufficient node on our network. Every manufacturing node operates under the same rigorous quality, regulatory, and logistical controls, managed by our central control tower, enabling complex therapies to be produced and delivered where others simply can't reach.
REALM Bio ignites self-sustaining biotech ecosystems by embedding hands-on mentorship for local clinicians, technicians, and logistics teams directly within our platform. Every segment of 1REALM shares responsibility for training and supporting local talent in platform-specific protocols. Our nonprofit partner, the Global Access Alliance for Advanced Therapies (GAAAT), leads community engagement and advocacy, fostering trust and empowering a skilled workforce to deliver life-changing treatments where they're needed most.
